Game Creek Capital’s Pfizer PFE Stock Holding History

Game Creek Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-160,000	Closed	-$4.61M	–	69
2023 Q4	$4.61M	Buy	+160,000	New	+$4.84M	1.93%	14
2021 Q3	–	Sell	-70,000	Closed	-$2.74M	–	77
2021 Q2	$2.74M	Buy	+70,000	New	+$2.72M	1.38%	27
2020 Q3	–	Sell	-126,480	Closed	-$3.92M	–	62
2020 Q2	$3.92M	Buy	+126,480	New	+$4.3M	3.22%	14

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Game Creek Capital's PFE Position: Q2 2026 in Review

Game Creek Capital reduced its Pfizer (PFE) stake by 39% in Q2 2026, selling an estimated $1.36M and leaving 82,500 shares worth $1.99M. The position accounts for 0.7% of the portfolio, ranked #44.

Game Creek Capital first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $16.1M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Game Creek Capital held 82,500 shares of Pfizer worth $1.99M as of Q2 2026.
Game Creek Capital sold 51,875 Pfizer shares in Q2 2026, an estimated $1.36M.
Pfizer made up 0.7% of Game Creek Capital's portfolio in Q2 2026, its #44 holding.
Game Creek Capital first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
Game Creek Capital's Pfizer position peaked at $16.1M in Q4 2021.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.